Contributor Page
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
Email  |  Website  |  Articles
Contact Details
Tel: +1 202 4084000
Fax: +1 202 4084400
901 New York Avenue, NW
Washington, DC
DC 20001-4413
United States
By Nathan I. North
In Sanofi v. Watson, No. 2016-2722, the Federal Circuit affirmed the district court's decision, upholding induced infringement and validity of Sanofi's patents covering compositions of, uses for...
By Brian Kacedon, John Paul, Sonja Sahlsten
Submitting an Abbreviated New Drug Application (ANDA) and subsequent prospective infringement can be sufficient to show an act of infringement under the venue statute.
By Brian Kacedon, John Paul, Lauren Dowty
Claims regarding patent ownership and infringement are not ripe for decision by federal courts until state law claims regarding ownership are resolved.
By Brian Kacedon, John Paul, Kelly Lu
Having a handful of employees who are not involved in the acts of infringement does not establish a "regular and established place of business" to satisfy the venue statute...
By Daniel Klodowski, David Seastrunk, Michael R Galgano
The Patent Trial and Appeal Board issued 44 IPR and CBM Final Written Decisions in October, cancelling 623 (70%) instituted claims while declining to cancel 267 (30%) instituted claims.
By Brian Kacedon, John Paul, Laith Abu-Taleb
The Federal Circuit affirmed a California court's decision that Waymo and Uber were not required to arbitrate their trade secret dispute.
By Ashley Winkler
In Promega Corporation v. Life Technologies Corporation, Nos. 2013‑1011, ‑1029, ‑1376 (Fed. Cir. Nov. 3, 2017), on remand from the Supreme Court, the Federal Circuit reviewed ...
By Jonathan Uffelman
The District of Maryland ruled that the mere threat of a TTAB cancellation proceeding is not sufficient to create a case or controversy to allow the trademark owner to bring a declaratory judgment action ...
By Jonathan Uffelman
Deere & Company has for more than 100 years sold a wide variety of agricultural, forestry, lawn, and garden equipment.
By Thomas Irving, Paula E. Miller, Marianne Terrot PhD, Stacey Lewis
While some may take it as a given that patent owners view America Invents Act post-grant proceedings—inter partes reviews and post-grant reviews—as disadvantageously weakening the U.S. patent system ...
By Charles Collins-Chase, Paul Townsend
The U.S. Supreme Court will soon hear argument in two patent cases that cut to the heart of the PTAB authority to adjudicate patent validity through inter partes review (IPR) proceedings.
By Finnegan, Henderson, Farabow, Garrett & Dunner, LLP
A Quick Patent Information Disclosure Statement (QPIDS) submission may be filed in a reissue application, but is not applicable in a design or plant application or to reexamination proceedings.
By John Nappi
The Federal Circuit affirmed the decision of the Delaware District Court in Two-Way Media, Ltd. v. Comcast Cable Communications, Inc., Nos. 16-2531, 16-2532 (Fed. Cir. Nov. 1, 2017), determining ...
By James M. Eaton
In Bayer Pharma AG v. Watson Labs., Inc., No. 2016-2169 (Fed. Cir. Nov. 1, 2017), the Federal Circuit reversed the district court's conclusion that certain claims of Bayer's patent
By Umber Aggarwal
In MasterMine Software, Inc. v. Microsoft Corp., No. 2016-2465 (Fed. Cir. Oct. 30, 2017), the Federal Circuit affirmed the district court's claim construction and reversed the district court's finding...
Contributor's Topics